SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Bioorganic & medicinal chemistry letters
Bioorg Med Chem Lett
ISSN 1464-3405
584 views
Indexed In
ncbi
ulakbim
Publications
246
ULAKBİM
MEP: 498
Ödeme: 2490
Yılı: 2019
Details
Abbreviated Name
bioorg med chem lett
ISSN
1464-3405
Publications/Year
Top Clicked Bibliographies from Search
138
time cost of a nonclosing intravenous thrombolysis service for acute ischemic stroke
2015
440 clicks
16
Meeting organometallic chemistry with drug discovery: CH activation enabled discovery of a new ring system of 12H-Indazolo[2,1-a]cinnolin-12-ones with anti-proliferation activity.
2020
366 clicks
20
An efficient synthetic approach toward a sporadic heterocyclic scaffold: 1,3-Oxathiol-2-ylidenes; alkaline phosphatase inhibition and molecular docking studies.
2020
356 clicks
61
repair of articular cartilage defects: review and perspectives
2009
347 clicks
1
Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors.
2017
346 clicks
4
Synthesis and anticancer evaluation of novel triazole linked N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine derivatives as inhibitors of cell survival proteins and inducers of apoptosis in MCF-7 breast cancer cells.
2015
335 clicks
12
Discovery of pyrazolone spirocyclohexadienone derivatives with potent antitumor activity.
2020
331 clicks
19
Synthesis, antimycobacterial activity and docking study of 2-aroyl-[1]benzopyrano[4,3-c]pyrazol-4(1H)-one derivatives and related hydrazide-hydrazones.
2017
314 clicks
10
Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach.
2019
307 clicks
243
Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines.
2021
305 clicks